Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Proprotein convertase furin regulates osteocalcin and bone endocrine function
Omar Al Rifai, … , Nabil G. Seidah, Mathieu Ferron
Omar Al Rifai, … , Nabil G. Seidah, Mathieu Ferron
Published October 3, 2017
Citation Information: J Clin Invest. 2017;127(11):4104-4117. https://doi.org/10.1172/JCI93437.
View: Text | PDF
Research Article Bone biology Metabolism

Proprotein convertase furin regulates osteocalcin and bone endocrine function

  • Text
  • PDF
Abstract

Osteocalcin (OCN) is an osteoblast-derived hormone that increases energy expenditure, insulin sensitivity, insulin secretion, and glucose tolerance. The cDNA sequence of OCN predicts that, like many other peptide hormones, OCN is first synthesized as a prohormone (pro-OCN). The importance of pro-OCN maturation in regulating OCN and the identity of the endopeptidase responsible for pro-OCN cleavage in osteoblasts are still unknown. Here, we show that the proprotein convertase furin is responsible for pro-OCN maturation in vitro and in vivo. Using pharmacological and genetic experiments, we also determined that furin-mediated pro-OCN cleavage occurred independently of its γ-carboxylation, a posttranslational modification that is known to hamper OCN endocrine action. However, because pro-OCN is not efficiently decarboxylated and activated during bone resorption, inactivation of furin in osteoblasts in mice resulted in decreased circulating levels of undercarboxylated OCN, impaired glucose tolerance, and reduced energy expenditure. Furthermore, we show that Furin deletion in osteoblasts reduced appetite, a function not modulated by OCN, thus suggesting that osteoblasts may secrete additional hormones that regulate different aspects of energy metabolism. Accordingly, the metabolic defects of the mice lacking furin in osteoblasts became more apparent under pair-feeding conditions. These findings identify furin as an important regulator of bone endocrine function.

Authors

Omar Al Rifai, Jacqueline Chow, Julie Lacombe, Catherine Julien, Denis Faubert, Delia Susan-Resiga, Rachid Essalmani, John W.M. Creemers, Nabil G. Seidah, Mathieu Ferron

×

Figure 1

A PC cleaves pro-OCN at the RXRR motif in osteoblasts.

Options: View larger image (or click on image) Download as PowerPoint
A PC cleaves pro-OCN at the RXRR motif in osteoblasts.
(A) Schematic rep...
(A) Schematic representation of the pre-pro-OCN protein including the approximate positions of the Gla residues, and amino acid alignment of OCN propeptide sequences from various vertebrate species: the conserved RX(R/K)R motif is highlighted in yellow. Consensus symbols are included below the alignment. A single asterisk indicates a fully conserved residue; a colon indicates a strongly conserved residue; a period indicates moderate or weak conservation. (B) Western blot analysis of cell supernatant from primary osteoblasts transfected with OCN-V5 or an R46A/R48A/R49A OCN mutant (OCNAAA-V5), both tagged at the C-terminal with the V5 epitope. (C) Western blot analysis of endogenous OCN in the cell supernatant from differentiated mouse calvaria osteoblasts treated or not with 50 μM Dec-RVKR-CMK (RVKR). (D) Western blot analysis of cell supernatant and cell extracts of CHO-ldlD cells transfected with OCN-V5 and treated or not with 50 μM Dec-RVKR-CMK. (E) Western blot analysis of the supernatant of primary osteoblasts transfected with OCN-V5 or OCNAAA-V5 and treated or not with 50 μM Dec-RVKR-CMK or 20 μM D6R. IB, immunoblot.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts